Clinical trials
Active, not recruiting Phase 2 Kidney Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2022 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 2 |
| Actuate Therapeutics Inc. | 1 |
| Dana-Farber Cancer Institute | 1 |
| Emory University | 1 |
| Hospital das Clínicas de Ribeirão Preto | 1 |
| M.D. Anderson Cancer Center | 1 |
| Mark Stein | 1 |
| Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| Providence Health & Services | 1 |
| Toni Choueiri, MD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Neoplasms | 13 |
| Carcinoma, Renal Cell | 8 |
| Lung Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
| Bone Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Colorectal Neoplasms | 1 |
| Glioma | 1 |
| Hereditary Sensory and Autonomic Neuropathies | 1 |
| Leukemia-Lymphoma, Adult T-Cell | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.